{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:05:55Z","timestamp":1755907555535,"version":"3.44.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16886-6","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:59:53Z","timestamp":1755845993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of the number of non-opioid psychotropic medications and their co-exposures during pregnancy on short-term outcomes in full-term neonates"],"prefix":"10.1038","volume":"15","author":[{"given":"Hitoshi","family":"Isohata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumie","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Shimaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Inada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigo","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"16886_CR1","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1097\/AOG.0000000000000759","volume":"125","author":"CG Coughlin","year":"2015","unstructured":"Coughlin, C. G. et al. Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet. Gynecol. 125, 1224\u20131235. https:\/\/doi.org\/10.1097\/AOG.0000000000000759 (2015).","journal-title":"Obstet. Gynecol."},{"key":"16886_CR2","doi-asserted-by":"publisher","unstructured":"Treatment and management of mental health conditions during pregnancy and postpartum: ACOG clinical practice guideline No. 5. Obstet Gynecol 141 1262-1288, https:\/\/doi.org\/10.1097\/AOG.0000000000005202 (2023).","DOI":"10.1097\/AOG.0000000000005202"},{"key":"16886_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7394","volume":"349","author":"LM Howard","year":"2014","unstructured":"Howard, L. M., Megnin-Viggars, O., Symington, I., Pilling, S. & Guideline Development, G. Antenatal and postnatal mental health: Summary of updated NICE guidance. BMJ 349, g7394. https:\/\/doi.org\/10.1136\/bmj.g7394 (2014).","journal-title":"BMJ"},{"key":"16886_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.midw.2020.102690","volume":"86","author":"N Baker","year":"2020","unstructured":"Baker, N., Gillman, L. & Coxon, K. Assessing mental health during pregnancy: An exploratory qualitative study of midwives\u2019 perceptions. Midwifery 86, 102690. https:\/\/doi.org\/10.1016\/j.midw.2020.102690 (2020).","journal-title":"Midwifery"},{"key":"16886_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.whi.2022.12.001","volume":"33","author":"JD Runkle","year":"2023","unstructured":"Runkle, J. D., Risley, K., Roy, M. & Sugg, M. M. Association between perinatal mental health and pregnancy and neonatal complications: A retrospective birth cohort study. Womens Health Issues 33, 289\u2013299. https:\/\/doi.org\/10.1016\/j.whi.2022.12.001 (2023).","journal-title":"Womens Health Issues"},{"key":"16886_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00737-018-0915-1","volume":"22","author":"R Boukakiou","year":"2019","unstructured":"Boukakiou, R., Glangeaud-Freudenthal, N. M. C., Falissard, B., Sutter-Dallay, A. L. & Gressier, F. Impact of a prenatal episode and diagnosis in women with serious mental illnesses on neonatal complications (prematurity, low birth weight, and hospitalization in neonatal intensive care units). Arch. Womens Ment. Health 22, 439\u2013446. https:\/\/doi.org\/10.1007\/s00737-018-0915-1 (2019).","journal-title":"Arch. Womens Ment. Health"},{"key":"16886_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/wps.20769","volume":"19","author":"LM Howard","year":"2020","unstructured":"Howard, L. M. & Khalifeh, H. Perinatal mental health: A review of progress and challenges. World Psychiatr. 19, 313\u2013327. https:\/\/doi.org\/10.1002\/wps.20769 (2020).","journal-title":"World Psychiatr."},{"key":"16886_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003062","author":"A Sadowski","year":"2013","unstructured":"Sadowski, A., Todorow, M., YazdaniBrojeni, P., Koren, G. & Nulman, I. Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. BMJ Open https:\/\/doi.org\/10.1136\/bmjopen-2013-003062 (2013).","journal-title":"BMJ Open"},{"key":"16886_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3326","volume":"358","author":"KF Huybrechts","year":"2017","unstructured":"Huybrechts, K. F. et al. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. BMJ 358, j3326. https:\/\/doi.org\/10.1136\/bmj.j3326 (2017).","journal-title":"BMJ"},{"key":"16886_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/ajo.12621","volume":"57","author":"J Frayne","year":"2017","unstructured":"Frayne, J. et al. The effects of gestational use of antidepressants and antipsychotics on neonatal outcomes for women with severe mental illness. Aust. N. Z J. Obstet. Gynaecol. 57, 526\u2013532. https:\/\/doi.org\/10.1111\/ajo.12621 (2017).","journal-title":"Aust. N. Z J. Obstet. Gynaecol."},{"key":"16886_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1017\/S1092852920001522","volume":"26","author":"D Morimoto","year":"2021","unstructured":"Morimoto, D. et al. Head circumference in infants with nonopiate-induced neonatal abstinence syndrome. CNS Spectr. 26, 509\u2013512. https:\/\/doi.org\/10.1017\/S1092852920001522 (2021).","journal-title":"CNS Spectr."},{"issue":"5","key":"16886_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/jog.15438","volume":"49","author":"A Itakura","year":"2023","unstructured":"Itakura, A. et al. Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 edition. J. Obstet. Gynaecol. Res. 49(5), 53. https:\/\/doi.org\/10.1111\/jog.15438 (2023).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"16886_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00788743","volume":"28","author":"A Janca","year":"1993","unstructured":"Janca, A., Ustun, T. B., Early, T. S. & Sartorius, N. The ICD-10 symptom checklist: A companion to the ICD-10 classification of mental and behavioural disorders. Soc. Psychiatry Psychiatr. Epidemiol. 28, 239\u2013242. https:\/\/doi.org\/10.1007\/BF00788743 (1993).","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"16886_CR14","unstructured":"Flockhart, D. A. Cytochrome P450 Drug Interaction Table, 2017)."},{"key":"16886_CR15","unstructured":"GenomeNet, <https:\/\/www.kegg.jp\/kegg\/drug\/drug_ja.html> ("},{"key":"16886_CR16","first-page":"65","volume":"14","author":"K Isobe","year":"1996","unstructured":"Isobe, K. et al. Management of neonatal withdrawal syndrome and drug metabolism: Anticonvulsants and psychotropic drugs. Symposium Perinatol. 14, 65\u201375 (1996).","journal-title":"Symposium Perinatol."},{"key":"16886_CR17","first-page":"141","volume":"2","author":"LP Finnegan","year":"1975","unstructured":"Finnegan, L. P., Connaughton, J. F. Jr., Kron, R. E. & Emich, J. P. Neonatal abstinence syndrome: assessment and management. Addict Dis. 2, 141\u2013158 (1975).","journal-title":"Addict Dis."},{"key":"16886_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061328","volume":"12","author":"E Heinonen","year":"2022","unstructured":"Heinonen, E., Forsberg, L., Norby, U., Wide, K. & Kallen, K. Neonatal morbidity after fetal exposure to antipsychotics: A national register-based study. BMJ Open 12, e061328. https:\/\/doi.org\/10.1136\/bmjopen-2022-061328 (2022).","journal-title":"BMJ Open"},{"key":"16886_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12884-018-1750-0","volume":"18","author":"QY Zhong","year":"2018","unstructured":"Zhong, Q. Y. et al. Adverse obstetric and neonatal outcomes complicated by psychosis among pregnant women in the United States. BMC Pregnancy Childbirth 18, 120. https:\/\/doi.org\/10.1186\/s12884-018-1750-0 (2018).","journal-title":"BMC Pregnancy Childbirth"},{"key":"16886_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12911-022-01870-1","volume":"22","author":"N Hussain-Shamsy","year":"2022","unstructured":"Hussain-Shamsy, N. et al. The development of a patient decision aid to reduce decisional conflict about antidepressant use in pregnancy. BMC Med. Inform Decis. Mak. 22, 130. https:\/\/doi.org\/10.1186\/s12911-022-01870-1 (2022).","journal-title":"BMC Med. Inform Decis. Mak."},{"key":"16886_CR21","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1056\/NEJMsa1500439","volume":"372","author":"VN Tolia","year":"2015","unstructured":"Tolia, V. N. et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N. Engl. J. Med. 372, 2118\u20132126. https:\/\/doi.org\/10.1056\/NEJMsa1500439 (2015).","journal-title":"N. Engl. J. Med."},{"key":"16886_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/acps.13367","volume":"145","author":"A Kautzky","year":"2022","unstructured":"Kautzky, A., Slamanig, R., Unger, A. & Hoflich, A. Neonatal outcome and adaption after in utero exposure to antidepressants: A systematic review and meta-analysis. Acta Psychiatr. Scand 145, 6\u201328. https:\/\/doi.org\/10.1111\/acps.13367 (2022).","journal-title":"Acta Psychiatr. Scand"},{"key":"16886_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/phar.2315","volume":"39","author":"CV Dave","year":"2019","unstructured":"Dave, C. V. et al. Prevalence of maternal-risk factors related to neonatal abstinence syndrome in a commercial claims database: 2011\u20132015. Pharmacotherapy 39, 1005\u20131011. https:\/\/doi.org\/10.1002\/phar.2315 (2019).","journal-title":"Pharmacotherapy"},{"key":"16886_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/archdischild-2023-326049","volume":"109","author":"MC Cornet","year":"2024","unstructured":"Cornet, M. C. et al. Maternal treatment with selective serotonin reuptake inhibitors during pregnancy and delayed neonatal adaptation: A population-based cohort study. Arch. Dis. Child Fetal. Neonatal. Ed. 109, 294\u2013300. https:\/\/doi.org\/10.1136\/archdischild-2023-326049 (2024).","journal-title":"Arch. Dis. Child Fetal. Neonatal. Ed."},{"key":"16886_CR25","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4088\/JCP.14m09070","volume":"76","author":"AL Sutter-Dallay","year":"2015","unstructured":"Sutter-Dallay, A. L. et al. Impact of prenatal exposure to psychotropic drugs on neonatal outcome in infants of mothers with serious psychiatric illnesses. J. Clin. Psychiatr. 76, 967\u2013973. https:\/\/doi.org\/10.4088\/JCP.14m09070 (2015).","journal-title":"J. Clin. Psychiatr."},{"key":"16886_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1001\/jamapsychiatry.2013.684","volume":"70","author":"LE Ross","year":"2013","unstructured":"Ross, L. E. et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: A systematic review and meta-analysis. JAMA Psychiat. 70, 436\u2013443. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.684 (2013).","journal-title":"JAMA Psychiat."},{"key":"16886_CR27","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2147\/NDT.S36394","volume":"9","author":"N Kieviet","year":"2013","unstructured":"Kieviet, N., Dolman, K. M. & Honig, A. The use of psychotropic medication during pregnancy: how about the newborn?. Neuropsychiatr. Dis Treat 9, 1257\u20131266. https:\/\/doi.org\/10.2147\/NDT.S36394 (2013).","journal-title":"Neuropsychiatr. Dis Treat"},{"key":"16886_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1055\/s-0028-1103296","volume":"42","author":"J Rampono","year":"2009","unstructured":"Rampono, J. et al. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry 42, 95\u2013100. https:\/\/doi.org\/10.1055\/s-0028-1103296 (2009).","journal-title":"Pharmacopsychiatry"},{"key":"16886_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00007691-200002000-00025","volume":"22","author":"K Otani","year":"2000","unstructured":"Otani, K. & Aoshima, T. Pharmacogenetics of classical and new antipsychotic drugs. Ther. Drug Monit. 22, 118\u2013121. https:\/\/doi.org\/10.1097\/00007691-200002000-00025 (2000).","journal-title":"Ther. Drug Monit."},{"key":"16886_CR30","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.1038\/s41598-021-85022-x","volume":"11","author":"ML Dahl","year":"2021","unstructured":"Dahl, M. L. et al. CYP2D6-inhibiting drugs and risk of fall injuries after newly initiated antidepressant and antipsychotic therapy in a Swedish, register-based case-crossover study. Sci. Rep. 11, 5796. https:\/\/doi.org\/10.1038\/s41598-021-85022-x (2021).","journal-title":"Sci. Rep."},{"key":"16886_CR31","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2165\/11318070-000000000-00000","volume":"48","author":"SF Zhou","year":"2009","unstructured":"Zhou, S. F. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part II. Clin. Pharmacokinet 48, 761\u2013804. https:\/\/doi.org\/10.2165\/11318070-000000000-00000 (2009).","journal-title":"Clin. Pharmacokinet"},{"key":"16886_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2188\/jea.JE20180014","volume":"29","author":"H Mezawa","year":"2019","unstructured":"Mezawa, H. et al. Prevalence of congenital anomalies in the japan environment and children\u2019s study. J. Epidemiol. 29, 247\u2013256. https:\/\/doi.org\/10.2188\/jea.JE20180014 (2019).","journal-title":"J. Epidemiol."},{"key":"16886_CR33","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/jdi.13044","volume":"10","author":"N Iwama","year":"2019","unstructured":"Iwama, N. et al. Difference in the prevalence of gestational diabetes mellitus according to gestational age at 75-g oral glucose tolerance test in Japan: The Japan assessment of gestational diabetes mellitus screening trial. J. Diabetes Investig. 10, 1576\u20131585. https:\/\/doi.org\/10.1111\/jdi.13044 (2019).","journal-title":"J. Diabetes Investig."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16886-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16886-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16886-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:59:55Z","timestamp":1755845995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16886-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16886"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16886-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Kitasato University School of Medicine and Hospital Ethics Committee approved the waiver of written informed consent and opt-out informed consent was employed due to the retrospective study design.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and approved by the Kitasato University School of Medicine and Hospital Ethics Committee (approval number: B24-085).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"30853"}}